Green Cross to supply $12M worth of flu vaccines to PAHO; Australian government orders anti-vaccine group to change name;

 @AlisonBFierce: Sanofi Pasteur MSD's recall of its typhoid vaccine has led to a shortage in the U.K. More | Follow @AlisonBFierce

> Dr. Gary R. Matyas won $5 million from the National Institute on Drug Abuse to develop a vaccine against HIV that also prevents heroin addiction. Story

> South Korea's Green Cross won a contract to supply $12 million worth of flu vaccines to the Pan American Health Organization. News

> The Australian government ordered an anti-vaccine group to change its name because it "poses a serious risk of misleading the community." Report

> Cuba patented a new lung cancer vaccine, dubbed Racotumomab. Article

And Finally... Immunovaccine reported positive results from an ongoing study of DepoVax-based anthrax vaccines. Release

Suggested Articles

Novavax will have billions of doses of COVID-19 vaccine capacity next year and could single-handedly meet U.S. demand, executives said.

As top players race to deliver COVID-19 vaccines, Russia approved a locally developed shot based on skimpy data. Experts called it a political stunt.

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan